Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market sale Director sold 1 shares at $6.00 ($6)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Exercise or conversion Director acquired 3,000 shares (option exercise)
  13. 4 Shares withheld for taxes Chief Medical Officer gave up 3,744 shares (to pay taxes)
  14. 4 Exercise or conversion Director acquired 3,000 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 3,000 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 3,250 shares (option exercise)
  17. 4 Shares withheld for taxes President and COO gave up 4,148 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 2,956 shares (to pay taxes)
  19. 4 Exercise or conversion Chief Financial Officer acquired 10,800 shares (option exercise)
  20. 4 Exercise or conversion CEO acquired 37,533 shares (option exercise)

Page 8 of 23 · 459 filings